Updates from HRS 2013!

hrs-2013

Late-Breaking Clinical Trials Session Presents Practice-Changing Data Current practice guidelines typically recommend discontinuing oral anticoagulation with warfarin for patients undergoing cardiac procedures, but two studies from Thursday’s Late-Breaking Clinical Trials session suggest that patients may do better if warfarin therapy is continued. Discontinuation of oral warfarin carries a 13-fold risk for periprocedural stroke and hemorrhagic […]